Type 2 diabetes mellitus was treated in 19.5% in the first group and 22.6% in the second; in both groups, more than 50% of patients were treated with insulin, whereas metformin was the most commonly prescribed anti-diabetic drug. This evidence concerns the gene INS and type 2 diabetes mellitus.